Richard Ganz

Mr. Ganz has an extensive background both as entrepreneur and as an executive with large health care organizations as well as in the start-up environment. He previously served as President of the North American Renal Business for Baxter International Inc., Divisional VP and General Manager of Vascular Medicine at Abbott Laboratories, and as CEO of OmniSonics Medical Technologies. He is currently President and CEO of Aarvon Biosciences and Executive in Residence at the Cleveland Clinic.